SIRT3 and Sepsis: Tan et al. [93] revealed that the aerobic glycolysis inhibitor 2-DG increased autophagy via the Sirtuin 3/AMPK pathway in CLP-induced sepsis mice resulting in protection against sepsis-associated AKI.